wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38851523-0367A546-30F8-4330-BE05-9294816D7E37
Q38851523-0367A546-30F8-4330-BE05-9294816D7E37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38851523-0367A546-30F8-4330-BE05-9294816D7E37
Current and future pharmacotherapy for treating overactive bladder.
P2860
Q38851523-0367A546-30F8-4330-BE05-9294816D7E37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38851523-0367A546-30F8-4330-BE05-9294816D7E37
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a17bc741f42d2e77a34f33ee51d191140d4d47c2
P2860
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.